1 min to read News Posted on March 24, 2023 Bayer deprioritizes women's health R&D – FierceBiotech Bayer deprioritizes women's health R&D FierceBiotech Source: Bayer deprioritizes women's health R&D – FierceBiotech share tweet share 5 things you really should not buy in 2023 – MorningstarHow a SPAC works?By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawReport: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPAC Tags: SPACs